Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
出版年份 2015 全文链接
标题
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
作者
关键词
Prostate cancer, Acetones, Lymphocytes, Blood, Immunofluorescence, Vimentin, Immunostaining, DU145 cells
出版物
PLoS One
Volume 10, Issue 9, Pages e0138032
出版商
Public Library of Science (PLoS)
发表日期
2015-09-24
DOI
10.1371/journal.pone.0138032
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cytospin preparation of AML in pleural fluid
- (2014) J. Hanenberg et al. BLOOD
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
- (2014) Brigitte Rack et al. JNCI-Journal of the National Cancer Institute
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis
- (2014) Akiko Yusa et al. PLoS One
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay
- (2014) Wael Harb et al. Translational Oncology
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
- (2012) Tobias M Gorges et al. BMC CANCER
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- Considerations in the development of circulating tumor cell technology for clinical use
- (2012) David R Parkinson et al. Journal of Translational Medicine
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- 'Cut and stick' ion gels
- (2012) Masashi Kawasaki et al. NATURE
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
- (2011) A. J. Armstrong et al. MOLECULAR CANCER RESEARCH
- HER2-Positive Circulating Tumor Cells in Breast Cancer
- (2011) Michail Ignatiadis et al. PLoS One
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular Biomarker Analyses Using Circulating Tumor Cells
- (2010) Elizabeth A. Punnoose et al. PLoS One
- Malignant cells facilitate lung metastasis by bringing their own soil
- (2010) D. G. Duda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
- (2010) S. L. Stott et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
- (2009) A. H. Talasaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic Spread Is an Early Step in Breast Cancer
- (2008) Yves Hüsemann et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started